HRP960259A2 - Method for preparing n-monosubstituted and n,n'-disubstitited unsymmetrical cyclic ureas - Google Patents

Method for preparing n-monosubstituted and n,n'-disubstitited unsymmetrical cyclic ureas Download PDF

Info

Publication number
HRP960259A2
HRP960259A2 HR481,683A HRP960259A HRP960259A2 HR P960259 A2 HRP960259 A2 HR P960259A2 HR P960259 A HRP960259 A HR P960259A HR P960259 A2 HRP960259 A2 HR P960259A2
Authority
HR
Croatia
Prior art keywords
substituted
alkyl
benzyl
independently selected
nr13r14
Prior art date
Application number
HR481,683A
Other languages
English (en)
Croatian (hr)
Inventor
James David Rodgers
Jung-Hui Sun
Original Assignee
Du Pont Merck Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Merck Pharma filed Critical Du Pont Merck Pharma
Publication of HRP960259A2 publication Critical patent/HRP960259A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HR481,683A 1995-06-07 1996-06-06 Method for preparing n-monosubstituted and n,n'-disubstitited unsymmetrical cyclic ureas HRP960259A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/481,683 US5532357A (en) 1995-06-07 1995-06-07 Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas

Publications (1)

Publication Number Publication Date
HRP960259A2 true HRP960259A2 (en) 1997-10-31

Family

ID=23912954

Family Applications (1)

Application Number Title Priority Date Filing Date
HR481,683A HRP960259A2 (en) 1995-06-07 1996-06-06 Method for preparing n-monosubstituted and n,n'-disubstitited unsymmetrical cyclic ureas

Country Status (26)

Country Link
US (1) US5532357A (fr)
EP (2) EP1029859A1 (fr)
JP (1) JPH11506779A (fr)
KR (1) KR19990022467A (fr)
CN (1) CN1192209A (fr)
AR (1) AR002384A1 (fr)
AU (1) AU704535B2 (fr)
BR (1) BR9609493A (fr)
CA (1) CA2223391A1 (fr)
CZ (1) CZ381997A3 (fr)
EA (1) EA000363B1 (fr)
EE (1) EE9700330A (fr)
HR (1) HRP960259A2 (fr)
HU (1) HUP9900913A2 (fr)
IL (1) IL122424A0 (fr)
LT (1) LT4381B (fr)
LV (1) LV12045B (fr)
MX (1) MX9709652A (fr)
NO (1) NO975679L (fr)
NZ (1) NZ309648A (fr)
PL (1) PL323993A1 (fr)
SI (1) SI9620077A (fr)
SK (1) SK164397A3 (fr)
TW (1) TW358091B (fr)
WO (1) WO1996040652A1 (fr)
ZA (1) ZA964847B (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US6054597A (en) * 1995-11-14 2000-04-25 Dupont Pharmaceuticals Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
EA199900452A1 (ru) * 1996-11-08 2000-02-28 Дюпон Фармасьютикалз Компани 1-(3-аминоиндазол-5-ил)-3-фенилметилциклические мочевины, полезные в качестве ингибиторов вич-протеазы
US6218386B1 (en) 1996-11-08 2001-04-17 Dupont Pharmaceuticals A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
US5932570A (en) * 1996-11-08 1999-08-03 Dupont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
AU6870098A (en) * 1997-03-31 1998-10-22 Du Pont Merck Pharmaceutical Company, The Indazoles of cyclic ureas useful as hiv protease inhibitors
US6218534B1 (en) * 1997-10-06 2001-04-17 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
AU4698399A (en) * 1998-06-30 2000-01-17 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
CA2370141A1 (fr) 1999-05-26 2000-12-07 James D. Rodgers Inhibiteurs de transcriptase inverse du vih a base de 1,4-benzodiazepin-2-ones
US6313110B1 (en) * 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
WO2002078628A2 (fr) * 2001-03-28 2002-10-10 Bristol-Myers Squibb Company Derives de cyanamide, alkoxyamino, et d'uree de 1,3-benzodiazapines en tant qu'inhibiteur de la transcriptase inverse du vih
US7777030B2 (en) 2005-12-29 2010-08-17 Centre National de la Recherge Scientifique (CNRS) Compositions and methods for the treatment and prevention of disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69221309T2 (de) * 1991-10-11 1997-12-11 The Du Pont Merck Pharmaceutical Co., Wilmington, Del. Cyclische harnstoffe und analoga verwendbar als retrovirale proteasehemmer
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5430043A (en) * 1993-08-24 1995-07-04 G. D. Searle & Co. Platelet aggregation inhibitors
US5530124A (en) * 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US7344671B2 (en) 2003-11-26 2008-03-18 Glopak Inc. Optical sealing clamp and a method for sealing and cutting polymeric sheets with a laser
US7369013B2 (en) 2005-04-06 2008-05-06 Avago Technologies Wireless Ip Pte Ltd Acoustic resonator performance enhancement using filled recessed region

Also Published As

Publication number Publication date
ZA964847B (en) 1997-12-08
MX9709652A (es) 1998-03-29
NZ309648A (en) 1998-09-24
IL122424A0 (en) 1998-06-15
JPH11506779A (ja) 1999-06-15
EP0837855A1 (fr) 1998-04-29
EE9700330A (et) 1998-06-15
EP0837855A4 (fr) 1998-09-02
AU704535B2 (en) 1999-04-29
LT97188A (en) 1998-04-27
WO1996040652A1 (fr) 1996-12-19
PL323993A1 (en) 1998-04-27
KR19990022467A (ko) 1999-03-25
LT4381B (lt) 1998-09-25
HUP9900913A2 (hu) 1999-09-28
SK164397A3 (en) 2000-04-10
US5532357A (en) 1996-07-02
TW358091B (en) 1999-05-11
EP1029859A1 (fr) 2000-08-23
NO975679L (no) 1998-02-02
SI9620077A (sl) 1998-08-31
CN1192209A (zh) 1998-09-02
AR002384A1 (es) 1998-03-11
CZ381997A3 (cs) 1999-01-13
EA199800034A1 (ru) 1998-08-27
AU5986896A (en) 1996-12-30
BR9609493A (pt) 1999-03-02
LV12045B (en) 1998-09-20
NO975679D0 (no) 1997-12-05
CA2223391A1 (fr) 1996-12-19
LV12045A (lv) 1998-05-20
EA000363B1 (ru) 1999-06-24

Similar Documents

Publication Publication Date Title
KR102468430B1 (ko) 피리미디닐 티로신 키나아제 억제제
CA3110767A1 (fr) Derives de benzimidazolone, et analogues de ceux-ci, en tant que modulateurs d'il-17
JP7166028B2 (ja) 高活性stingタンパク質アゴニスト化合物
KR20180103683A (ko) Ccr2 조절제
JPH11512723A (ja) フィブリノゲン依存血小板凝集抑制物質としてのスピロ化合物
HRP960259A2 (en) Method for preparing n-monosubstituted and n,n'-disubstitited unsymmetrical cyclic ureas
CA3110436C (fr) Agoniste de proteine sting a haute activite
TW200524878A (en) Gabanergic modulators
AU2013288265A1 (en) Tetrahydroquinazolinone derivatives as PARP inhibitors
US5532356A (en) Method for preparing N,N'-disubstituted cyclic ureas
US20230399327A1 (en) High activity hpk1 kinase inhibitor
JP7281834B2 (ja) Pd-l1拮抗薬化合物
AU2020413555B2 (en) PD-L1 antagonist compound
CN116348117A (zh) Hpk1激酶抑制剂化合物
US5508400A (en) Preparation of cyclic urea compounds
TWI768781B (zh) 轉化生長因子-β受體抑制劑
TW202304434A (zh) 一種高活性的hpk1激酶抑制劑

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODBC Application rejected